![Svetlana Lucas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Svetlana Lucas
Directeur/Membre du Conseil chez ATYR PHARMA, INC.
Fortune : 26 820 $ au 31/05/2025
Profil
Svetlana Lucas currently works at Jasper Therapeutics, Inc., as Director from 2024, aTyr Pharma, Inc., as Independent Director from 2019, and Scribe Therapeutics, Inc., as Chief Business Officer from 2019.
Dr. Lucas also formerly worked at Amgen, Inc., as Head-Oncology & Inflammation from 2014 to 2015 and Tizona Therapeutics, Inc., as Senior Vice President-Business Development from 2015 to 2019.
Dr. Lucas received her doctorate degree in 2001 from California Institute of Technology and undergraduate degree in 1994 from Moscow State University Lomonosov.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ATYR PHARMA, INC. 0,01 % | 01/05/2025 | 6 000 ( 0,01 % ) | 26 820 $ | 31/05/2025 |
Dernières actualités sur Svetlana Lucas
Postes actifs de Svetlana Lucas
| Sociétés | Poste | Début |
|---|---|---|
| ATYR PHARMA, INC. | Directeur/Membre du Conseil | 28/06/2019 |
| JASPER THERAPEUTICS, INC. | Directeur/Membre du Conseil | 19/06/2024 |
Scribe Therapeutics, Inc.
 Scribe Therapeutics, Inc. BiotechnologyHealth Technology Scribe Therapeutics, Inc. engages in the development of in vivo therapies. It develops custom engineered enzymes and delivery modalities as part of a proprietary, evergreen platform for CRISPR-based genetic medicine. The company was founded by Jennifer A. Doudna, Benjamin L. Oakes, David F. Savage, and Brett T. Staahl and is headquartered in Berkeley, CA. | Corporate Officer/Principal | 01/06/2019 |
Anciens postes connus de Svetlana Lucas
| Sociétés | Poste | Fin |
|---|---|---|
Tizona Therapeutics, Inc.
 Tizona Therapeutics, Inc. BiotechnologyHealth Technology Tizona Therapeutics, Inc. is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. Its products include anti-ccr4 antibody for the treatment of cancer, il-35 antagonists for the treatment of cancer, and il-35 agonists for the treatment of autoimmune diseases. The company was founded by Charles G. Drake, Vijay K. Kuchroo, Drew M. Pardoll, Dario Vignali, Wayne A. Marasco and Jedd D. Wolchok and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/01/2019 |
| AMGEN INC. | Corporate Officer/Principal | 01/07/2015 |
Formation de Svetlana Lucas
California Institute of Technology | Doctorate Degree |
Moscow State University Lomonosov | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ATYR PHARMA, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| JASPER THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Tizona Therapeutics, Inc.
Tizona Therapeutics, Inc. BiotechnologyHealth Technology Tizona Therapeutics, Inc. is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. Its products include anti-ccr4 antibody for the treatment of cancer, il-35 antagonists for the treatment of cancer, and il-35 agonists for the treatment of autoimmune diseases. The company was founded by Charles G. Drake, Vijay K. Kuchroo, Drew M. Pardoll, Dario Vignali, Wayne A. Marasco and Jedd D. Wolchok and is headquartered in South San Francisco, CA. | Health Technology |
Scribe Therapeutics, Inc.
Scribe Therapeutics, Inc. BiotechnologyHealth Technology Scribe Therapeutics, Inc. engages in the development of in vivo therapies. It develops custom engineered enzymes and delivery modalities as part of a proprietary, evergreen platform for CRISPR-based genetic medicine. The company was founded by Jennifer A. Doudna, Benjamin L. Oakes, David F. Savage, and Brett T. Staahl and is headquartered in Berkeley, CA. | Health Technology |
